ATE246708T1 - Elatase-inhibitoren - Google Patents
Elatase-inhibitorenInfo
- Publication number
- ATE246708T1 ATE246708T1 AT95918993T AT95918993T ATE246708T1 AT E246708 T1 ATE246708 T1 AT E246708T1 AT 95918993 T AT95918993 T AT 95918993T AT 95918993 T AT95918993 T AT 95918993T AT E246708 T1 ATE246708 T1 AT E246708T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- elatase
- elastase
- compounds
- human neutrophil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25279994A | 1994-06-02 | 1994-06-02 | |
PCT/US1995/005618 WO1995033763A1 (en) | 1994-06-02 | 1995-05-05 | Novel elastase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE246708T1 true ATE246708T1 (de) | 2003-08-15 |
Family
ID=22957608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95918993T ATE246708T1 (de) | 1994-06-02 | 1995-05-05 | Elatase-inhibitoren |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0804465B1 (de) |
JP (1) | JP3623799B2 (de) |
KR (1) | KR100347285B1 (de) |
CN (1) | CN1149877A (de) |
AT (1) | ATE246708T1 (de) |
AU (1) | AU689589B2 (de) |
CA (1) | CA2189527C (de) |
DE (1) | DE69531459T2 (de) |
DK (1) | DK0804465T3 (de) |
ES (1) | ES2199992T3 (de) |
FI (1) | FI964781A (de) |
HU (1) | HU221197B1 (de) |
IL (1) | IL113940A (de) |
NO (1) | NO965097L (de) |
NZ (1) | NZ285565A (de) |
PT (1) | PT804465E (de) |
SI (1) | SI0804465T1 (de) |
TW (1) | TW403762B (de) |
WO (1) | WO1995033763A1 (de) |
ZA (1) | ZA954430B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU696292B2 (en) * | 1994-06-02 | 1998-09-03 | Merrell Pharmaceuticals Inc. | Acylated enol derivatives as prodrugs of elastase inhibitors |
ATE186305T1 (de) * | 1994-06-02 | 1999-11-15 | Merrell Pharma Inc | Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung |
US5948886A (en) * | 1996-11-20 | 1999-09-07 | Hoechst Marion Roussel, Inc. | Acylated enol derivatives of α-ketoesters and α-ketoamides |
US6172044B1 (en) | 1995-12-01 | 2001-01-09 | Aventis Pharmaceuticals Inc. | Acylated enol derivative of α-ketoesters and α-ketoamides |
US6767991B1 (en) | 1997-08-11 | 2004-07-27 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C inhibitor peptides |
DE602004010137T2 (de) | 2003-05-21 | 2008-09-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verbindungen als hepatitis c inhibitoren |
UY29016A1 (es) | 2004-07-20 | 2006-02-24 | Boehringer Ingelheim Int | Analogos de dipeptidos inhibidores de la hepatitis c |
CA2573346C (en) | 2004-07-20 | 2011-09-20 | Boehringer Ingelheim International Gmbh | Hepatitis c inhibitor peptide analogs |
AU2007253819B2 (en) | 2006-05-23 | 2011-02-17 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
EP2117537A1 (de) | 2007-02-09 | 2009-11-18 | Irm Llc | Verbindungen und zusammensetzungen als kanalaktivierende protease-hemmer |
AU2020349353A1 (en) | 2019-09-17 | 2022-04-14 | Duke University | Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease |
US20230218596A1 (en) | 2020-04-16 | 2023-07-13 | Mereo Biopharma 4 Limited | Methods involving neutrophil elastase inhibitor alvelestat for treating coronavirus infection |
WO2023067103A1 (en) | 2021-10-20 | 2023-04-27 | Mereo Biopharma 4 Limited | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8600263D0 (en) * | 1985-01-22 | 1986-02-12 | Ici America Inc | Peptide derivatives |
DE3683541D1 (de) * | 1985-06-07 | 1992-03-05 | Ici America Inc | Selektionierte difluorverbindungen. |
CA2021660A1 (en) * | 1989-07-26 | 1991-01-27 | Philippe Bey | Peptidase inhibitors |
EP0564561A4 (en) * | 1990-12-28 | 1994-08-10 | Georgia Tech Res Inst | Peptides ketoamides, ketoacids, and ketoesters |
AU655831B2 (en) * | 1991-08-22 | 1995-01-12 | Merrell Pharmaceuticals Inc. | Novel orally-active elastase inhibitors |
-
1995
- 1995-05-05 EP EP95918993A patent/EP0804465B1/de not_active Expired - Lifetime
- 1995-05-05 KR KR1019960706818A patent/KR100347285B1/ko not_active IP Right Cessation
- 1995-05-05 ES ES95918993T patent/ES2199992T3/es not_active Expired - Lifetime
- 1995-05-05 DE DE69531459T patent/DE69531459T2/de not_active Expired - Lifetime
- 1995-05-05 DK DK95918993T patent/DK0804465T3/da active
- 1995-05-05 HU HU9603312A patent/HU221197B1/hu not_active IP Right Cessation
- 1995-05-05 NZ NZ285565A patent/NZ285565A/en unknown
- 1995-05-05 AU AU24709/95A patent/AU689589B2/en not_active Ceased
- 1995-05-05 WO PCT/US1995/005618 patent/WO1995033763A1/en active IP Right Grant
- 1995-05-05 JP JP50087196A patent/JP3623799B2/ja not_active Expired - Fee Related
- 1995-05-05 SI SI9530682T patent/SI0804465T1/xx unknown
- 1995-05-05 AT AT95918993T patent/ATE246708T1/de not_active IP Right Cessation
- 1995-05-05 PT PT95918993T patent/PT804465E/pt unknown
- 1995-05-05 CA CA002189527A patent/CA2189527C/en not_active Expired - Fee Related
- 1995-05-05 CN CN95193386A patent/CN1149877A/zh active Pending
- 1995-05-30 ZA ZA954430A patent/ZA954430B/xx unknown
- 1995-05-31 IL IL11394095A patent/IL113940A/xx not_active IP Right Cessation
- 1995-05-31 TW TW084105515A patent/TW403762B/zh not_active IP Right Cessation
-
1996
- 1996-11-29 NO NO965097A patent/NO965097L/no not_active Application Discontinuation
- 1996-11-29 FI FI964781A patent/FI964781A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
IL113940A0 (en) | 1995-08-31 |
PT804465E (pt) | 2003-12-31 |
AU689589B2 (en) | 1998-04-02 |
CN1149877A (zh) | 1997-05-14 |
SI0804465T1 (en) | 2003-12-31 |
WO1995033763A1 (en) | 1995-12-14 |
KR100347285B1 (ko) | 2003-01-15 |
FI964781A0 (fi) | 1996-11-29 |
EP0804465B1 (de) | 2003-08-06 |
IL113940A (en) | 1999-12-31 |
DE69531459D1 (de) | 2003-09-11 |
HUT76926A (hu) | 1998-01-28 |
DK0804465T3 (da) | 2003-11-24 |
JPH10500992A (ja) | 1998-01-27 |
HU9603312D0 (en) | 1997-01-28 |
FI964781A (fi) | 1997-01-29 |
NO965097D0 (no) | 1996-11-29 |
JP3623799B2 (ja) | 2005-02-23 |
CA2189527A1 (en) | 1995-12-14 |
TW403762B (en) | 2000-09-01 |
EP0804465A1 (de) | 1997-11-05 |
ZA954430B (en) | 1996-02-13 |
NZ285565A (en) | 1998-08-26 |
NO965097L (no) | 1997-01-31 |
ES2199992T3 (es) | 2004-03-01 |
AU2470995A (en) | 1996-01-04 |
HU221197B1 (en) | 2002-08-28 |
CA2189527C (en) | 2000-12-19 |
MX9606030A (es) | 1998-05-31 |
DE69531459T2 (de) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
ES2135062T3 (es) | Pirazolo y pirrolopiridinas. | |
DK0793674T3 (da) | Inhibitorer af human neutrofil elastase | |
PT695758E (pt) | Amidas e esteres de pentapeptidos inibidores de cancro humano | |
PT1028954E (pt) | Imidazoles substituidos uteis no tratamento de doencas inflamatorias | |
TR200000059T2 (tr) | Piridin türevleri | |
BR9710737A (pt) | Pentafluorobenzenosulfonamidas e análogos. | |
DE69920757D1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
ES2192839T3 (es) | Timosina beta 4 oxidada. | |
ATE246708T1 (de) | Elatase-inhibitoren | |
DK0489877T3 (da) | Antiatherosklerotiske og antithrombotiske 2-amino-6-phenyl-4H-pyran-4-oner | |
AP2000001761A0 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. | |
ATE265455T1 (de) | Tetrahydropyridoverbindungen | |
ES2140672T3 (es) | Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos. | |
TR200001026T2 (tr) | Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri. | |
BRPI0415355A (pt) | triarilimidazóis | |
NO20005548L (no) | Mykobakterieinhibitorer | |
DE69726743D1 (de) | Peptid analoge, die einen siebengliedrigen lactamring enthalten | |
EA200100152A1 (ru) | Замещенные пиперазиноны и их терапевтическое применение | |
EA199800822A1 (ru) | Способ лечения избыточной агрессии | |
TR200003083T2 (tr) | CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate. | |
MX9606031A (es) | Inhibidores de cetona perfluoroalquilica de elastasa y procesos para fabricarlos. | |
PE61999A1 (es) | Compuestos de tetrahidropiridina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0804465 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |